Mist

* Over the past decade, 4 BPH stents have received FDA approval, with 2 nitinol-based stents—Zenflow and ProVee—entering the market in late 2025, marking a significant expansion of office-based treatment options. * Zorn places the rise of MISTs within the broader context of an aging male...

* Sexual function was preserved throughout the study follow-up period, with investigators reporting no incidence of de novo sustained retrograde ejaculation or erectile dysfunction. Key Takeaways The ProVee System received FDA approval for treating BPH, offering a safe and effective...

The Optimum BPH Catheter System Conclusion

* Dr. Moe Saffarzadeh, PGY-1 Resident, Department of Urologic Sciences, UBC

Introduction Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is often initially treated with medical therapy, an approach marked by high non-adherence rates; minimally invasive surgical therapies(MISTs) like the Prostatic Urethral Lift (PUL) offer a favorable...

* MIST procedures: low risk of ED and EjD Faysal A. Yafi, MD, FRCSC, Associate Professor and Vice-Chair of Urology, University of California, Irvine, Orange, California, discusses the transition from managing large prostates to addressing smaller prostates with minimally invasive...

With the abundance of interventional options for benign prostate hyperplasia (BPH), how do you decide on the best treatment for each individual patient? In this episode of BackTable Urology, Dr. Marawan El Tayeb, chief of urology at Baylor Scott and White-Temple, joins host Dr. Jose Silva to...

Garrett D. Pohlman, MD, Kearney Urology Center, P.C., Kearney, Nebraska, discusses that Optilume BPH is a promising, durable, and patient-friendly option in the evolving landscape of BPH treatments. In this 11-minute presentation, Pullman gives step-by-step instructions for the Optilume...

In Episode 91, we introduced the Optilume® procedure, a cutting-edge new solution for an enlarged prostate, or BPH, that requires no heating, cutting, or permanent implantation. Today, we bring you the story of how Dr. Sijo Parekattil, a leading urologist specializing in cutting-edge...

Today we are joined by Dr. Joel Hillelsohn, a board-certified urologist at New York University Medical Center. He also serves as a clinical assistant professor at the New York University Grossman School of Medicine. Dr. Hillelsohn joins us to discuss the BPH treatment options and which ones are...

David Crawford, MD, sits down with Dean S. Elterman, MD, MSC, FRCSC, and Stephen Kaplan, MD, to discuss the evolution of BPH treatment and the Optilume® BPH Catheter System, a novel minimally-invasive surgical therapy (MIST). This is the first in a series supported by Laborie. Dr. Elterman...

iTind™ *the first true MIST procedure * non permanent implant * no sexual side-effects Minimally invasive surgical therapies (MIST) have revolutionized treatment options for men suffering from symptoms of an enlarged prostate. So, we are excited to have urologist Dr. Rahul Mehan joining...

In this episode we discuss Optilume, a novel treatment for the urinary symptoms experienced by men due to an enlarged or obstructing prostate (BPH). In previous episodes, we have covered a variety of other BPH treatments ranging from the historical gold standard (TURP) to minimally invasive...

Steven A. Kaplan, MD, joins E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology, to discuss the results of the PINNACLE trial published in the September 2023 issue of the Journal of Urology. The PINNACLE trial was a Phase 3 study examining the effectiveness of treating benign...

In this episode of the Prostate Health Podcast, Dr. Steven Kaplan and Dr. Dean Alterman discuss Optilume BPH, a new treatment for benign enlargement of the prostate. Optilume BPH is a drug-coated balloon that does not require surgery or permanent implants. The doctors explain the procedure and...